Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) announced the completion of its acquisition of World Courier Group, Inc. on May 1, 2012. The transaction was valued at $520 million, with the final price subject to customary working capital adjustments. World Courier is a significant player in the biopharmaceutical industry, specializing in transportation and logistics services for sensitive and high-value biological materials.
Key Highlights
- 1AmerisourceBergen (now Cencora) has successfully acquired World Courier Group, Inc.
- 2The acquisition price was $520 million, subject to working capital adjustments.
- 3World Courier is a global specialty transportation and logistics provider.
- 4The target company serves the biopharmaceutical industry.
- 5The acquisition is expected to enhance AmerisourceBergen's capabilities in specialty logistics.
- 6The news release announcing the acquisition is furnished as an exhibit.
Frequently Asked Questions
This 8-K filing primarily serves to announce and provide details regarding the completion of Cencora's (then AmerisourceBergen) acquisition of World Courier Group, Inc. It includes a furnished news release detailing the transaction.
World Courier Group, Inc. is a global provider of specialty transportation and logistics services specifically for the biopharmaceutical industry. Its acquisition is significant as it likely expands Cencora's service offerings and geographic reach within the high-growth biopharmaceutical sector, particularly in areas requiring specialized handling and delivery.
The acquisition was completed for $520 million, with the final cost subject to adjustments based on working capital. This represents a substantial investment by Cencora, indicating a strategic move to bolster its position in the specialty logistics market.
No, this particular 8-K filing does not include detailed financial statements of World Courier Group, Inc. It primarily announces the event and refers to an attached news release. More detailed financial information would typically be found in subsequent filings or the company's full financial reports.